Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

10.95
Delayed Data
As of Jul 24
 -0.05 / -0.45%
Today’s Change
8.55
Today|||52-Week Range
11.10
+1.39%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Blobel Friedhelm
President & Chief Executive Officer
Sale8/17/2016501,875$10.00$5.0M+6.00%
Cheung Wai Shun /sciclone/
Chief Financial Officer & Senior Vice President
Sale10/26/201648,995$10.00$490.0K+11.17%
King Robert S
Sale8/12/201646,667$10.41$485.8K+5.19%
Cheung Wai Shun /sciclone/
Chief Financial Officer & Senior Vice President
Sale10/26/201645,208$10.00$452.1K+11.17%
Blobel Friedhelm
President & Chief Executive Officer
Sale6/20/201740,000$10.91$436.4K0.00%
Blobel Friedhelm
President & Chief Executive Officer
Sale12/21/201640,000$10.54$421.6K+3.79%
Blobel Friedhelm
President & Chief Executive Officer
Sale11/21/201640,000$10.22$408.8K+6.83%
Cheung Wai Shun /sciclone/
Chief Financial Officer & Senior Vice President
Sale10/26/201640,625$10.00$406.3K+11.17%
Blobel Friedhelm
President & Chief Executive Officer
Sale10/27/201640,000$9.30$372.0K+20.99%
Blobel Friedhelm
President & Chief Executive Officer
Sale6/20/201730,000$10.90$327.0K0.00%
Page of 19